Director/PDMR Shareholding
Updated : 16:38
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr S Dingemans | |||
b) | Position/status | Chief Financial Officer | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| |||
b) | Nature of the transaction | Transfer of 121,802 Ordinary Shares between accounts for nil consideration.
| |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| £0.00 | 121,802 |
| ||
|
|
|
| ||
d) | Aggregated information | n/a (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2019-02-20 | |||
f) | Place of the transaction
| n/a | |||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.